Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung

NCT05306288 is registered in ClinicalTrials.gov with Delfi Diagnostics Inc. as lead sponsor.

NCT NCT05306288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05306288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung
Lead sponsor
Delfi Diagnostics Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
April 7, 2022
Completion date
October 30, 2026
Enrollment
11,935 (actual)
Sites
67

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer